January 2007 | David E. Cummings and Joost Overduin
The gastrointestinal system plays a crucial role in regulating food intake through the gut-brain axis, which coordinates energy intake and expenditure to maintain body weight. The brain processes hormonal, neural, and metabolic signals from the gut to modulate appetite. Key mechanisms include gastric distention, intestinal and pancreatic satiation peptides, and the orexigenic hormone ghrelin. Enteroendocrine cells in the gut sense nutrients and release peptides that influence gastrointestinal motility and secretion, contributing to satiation and satiety. Satiation signals, such as those from the stomach and intestines, promote meal termination, while satiety signals regulate meal frequency. The stomach, small intestine, and pancreas are major sources of satiation signals, with the stomach primarily responding to mechanical distention and the intestine to nutrient content. CCK, GLP1, and oxytomodulin are key satiation peptides that reduce food intake by inhibiting gastric emptying and activating neural pathways. Ghrelin, in contrast, stimulates appetite and is regulated oppositely to satiation signals. The interaction between long-term adiposity hormones like leptin and insulin and short-term satiation signals is essential for energy homeostasis. Understanding these mechanisms provides potential targets for obesity and diabetes treatment. The gut-brain axis, involving enteroendocrine cells and neural pathways, is a promising area for developing new therapies. Future research aims to exploit these natural appetite-regulatory systems to achieve weight loss and metabolic benefits through pharmacological means.The gastrointestinal system plays a crucial role in regulating food intake through the gut-brain axis, which coordinates energy intake and expenditure to maintain body weight. The brain processes hormonal, neural, and metabolic signals from the gut to modulate appetite. Key mechanisms include gastric distention, intestinal and pancreatic satiation peptides, and the orexigenic hormone ghrelin. Enteroendocrine cells in the gut sense nutrients and release peptides that influence gastrointestinal motility and secretion, contributing to satiation and satiety. Satiation signals, such as those from the stomach and intestines, promote meal termination, while satiety signals regulate meal frequency. The stomach, small intestine, and pancreas are major sources of satiation signals, with the stomach primarily responding to mechanical distention and the intestine to nutrient content. CCK, GLP1, and oxytomodulin are key satiation peptides that reduce food intake by inhibiting gastric emptying and activating neural pathways. Ghrelin, in contrast, stimulates appetite and is regulated oppositely to satiation signals. The interaction between long-term adiposity hormones like leptin and insulin and short-term satiation signals is essential for energy homeostasis. Understanding these mechanisms provides potential targets for obesity and diabetes treatment. The gut-brain axis, involving enteroendocrine cells and neural pathways, is a promising area for developing new therapies. Future research aims to exploit these natural appetite-regulatory systems to achieve weight loss and metabolic benefits through pharmacological means.